Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 13:9:996057.
doi: 10.3389/fmolb.2022.996057. eCollection 2022.

Molecular regulation after mucosal injury and regeneration in ulcerative colitis

Affiliations
Review

Molecular regulation after mucosal injury and regeneration in ulcerative colitis

Lie Zheng et al. Front Mol Biosci. .

Abstract

Ulcerative colitis (UC) is a chronic nonspecific inflammatory disease with a complex etiology. Intestinal mucosal injury is an important pathological change in individuals with UC. Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5+) intestinal stem cells (ISCs) exhibit self-renewal and high differentiation potential and play important roles in the repair of intestinal mucosal injury. Moreover, LGR5+ ISCs are intricately regulated by both the Wnt/β-catenin and Notch signaling pathways, which jointly maintain the function of LGR5+ ISCs. Combination therapy targeting multiple signaling pathways and transplantation of LGR5+ ISCs may lead to the development of new clinical therapies for UC.

Keywords: intestinal stem cells; molecular regulation; mucosal injury; regeneration; ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
EGF signaling.
FIGURE 2
FIGURE 2
Hippo-YES-associated protein (YAP) pathway.
FIGURE 3
FIGURE 3
Notch signaling pathway.
FIGURE 4
FIGURE 4
BMP signaling pathway.
FIGURE 5
FIGURE 5
Mechanisms of action of Wnt/β-catenin signaling pathways.

Similar articles

Cited by

References

    1. Al-Hakeim H. K., Asad H. N., Maes M. (2021). Wnt/β-catenin pathway proteins in end-stage renal disease. Biomark. Med. 15 (15), 1423–1434. 10.2217/bmm-2021-0177 - DOI - PubMed
    1. Ali E. S., Sahu U., Villa E., O'Hara B. P., Gao P., Beaudet C., et al. (2020). ERK2 phosphorylates PFAS to mediate posttranslational control of de novo purine synthesis. Mol. Cell 78 (6), 1178–1191. e6. 10.1016/j.molcel.2020.05.001 - DOI - PMC - PubMed
    1. Allegra A., Pioggia G., Innao V., Musolino C., Gangemi S. (2021). New insights into YES-associated protein signaling pathways in hematological malignancies: Diagnostic and therapeutic challenges. Cancers (Basel) 13 (8), 1981. 10.3390/cancers13081981 - DOI - PMC - PubMed
    1. Ampuja M., Kallioniemi A. (2018). Transcription factors-Intricate players of the bone morphogenetic protein signaling pathway. Genes Chromosom. Cancer 57 (1), 3–11. 10.1002/gcc.22502 - DOI - PubMed
    1. Andriatsilavo M., Stefanutti M., Siudeja K., Perdigoto C. N., Boumard B., Gervais L., et al. (2018). Spen limits intestinal stem cell self-renewal. PLoS Genet. 14 (11), e1007773. 10.1371/journal.pgen.1007773 - DOI - PMC - PubMed

LinkOut - more resources